Waters Corporation
Waters Corporation Completes Acquisition of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions Business
Summary
Waters Corporation has completed the acquisition of Becton, Dickinson and Company's (BD) Biosciences and Diagnostic Solutions business, referred to as the SpinCo Business. The unaudited condensed combined financial statements for the SpinCo Business for the three months ended December 31, 2025, and 2024, show total net sales of $766 million and $834 million, respectively. The SpinCo Business reported net income of $49 million for the three months ended December 31, 2025, compared to $78 million for the same period in 2024. The acquisition is expected to enhance Waters' position in the life sciences market.
Profitelligence Alerts
Get alerts for WAT
Be first to know when Waters Corporation files with the SEC.
Filing Categories
Advertisement
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Official SEC Documents
Advertisement